Zur Pathogenese diabetischer Gefäßkomplikationen: Mögliche Beteiligung der nichtenzymatischen Glukosylierung von Proteinen

O. H. Wieland

doi:10.1055/s-0038-1656623

Hämostaseologie, Table of Contents

Hamostaseologie 1983; 03(03): 92-96
DOI: 10.1055/s-0038-1656623

Originalarbeiten

Schattauer GmbH

Zur Pathogenese diabetischer Gefäßkomplikationen: Mögliche Beteiligung der nichtenzymatischen Glukosylierung von Proteinen

O. H. Wieland

¹Aus dem Institut für Klinische Chemie und Forschergruppe Diabetes, Städtisches Krankenhaus (Akademisches Lehrkrankenhaus) München-Schwabing

› Author Affiliations

Abstract

Full Text

References

LITERATUR
1 Wieland O. H. Zur Rolle der Hyperglyk-ämie in der Pathobiochemie des Diabetes mellitus. Verh. Dtsch. Ges. Inn. Med 1981; 87: 1
2 Wieland O. H. Protein modification by non-enzymatic glucosylation: Possible role in the development of diabetic complications. Mol. Cell Endocrin 1983; 29: 125
3 Bunn H. F. Nonenzymatic glycosylation of protein: Relevance to diabetes. Amer. J. Med 1981; 70: 325
4 Mehl T. D, Wenzel S. E, Russel B, Gardner D, Merimee T. J. Comparison of two indices of glycemic control in diabetic subject: Glycosylated serum protein and hemoglobin. Diabetes Care 1983; 6: 34
5 McDonald M. J, Bleichmann M, Bunn H. F, Noble R. W. Functional properties of the glycosylated minor components of human adult hemoglobin. J. Biol. Chem 1979; 254: 702
6 Ditzel J. Affinity Hypoxia as a pathogenic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinol 1980; 94: 39
7 Samaja M, Melotti D, Carenini A, Pozza G. Glycosylated haemoglobins and the oxygen affinity of whole blood. Diabetolo-gia 1982; 23: 399
8 Williams S. K, Devenny J. J, Bitensky M. W. Micropinocytotic ingestion of glycosylated albumin by isolated microvessels: Possible role in pathogenesis of diabetic microangiopathy. Proc. Nat. Acad. Sci. USA 1981; 67: 2393
9 Jeray K. P, Michael A. F, Mauer S. M, Brown D. M. Glucosylated and normal human rat albumin do not bind to renal basement membranes of diabetic and control rats. Diabetes 1983; 32: 380
10 McVerry B. A, Hopp A, Fischer C, Huehns E. R. Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glucosylated proteins. Lancet 1980; I: 738
11 Schleicher E, Deufel T, Wieland O. H. Non-enzymatic glycosylation of human serum lipoprotein: Elevated E-lysine glycosylated low density lipoprotein in diabetic patients. FEBS-Lett 1981; 129: 1
12 Goldstein J. L, Brown M. S. The low density lipoprotein pathway and its relation to atherosclerosis. Ann. Rev. Biochem 1977; 46: 897
13 Witztum J. L, Mahoney E. M, Branks M. J, Fisher M. J, Elam R, Steinberg D. Nonenzymatic glucosylation of low density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283
14 Miller J. A, Gravallese E, Bunn H. F. Nonenzymatic glucosylation of erythrocyte membrane proteins: Relevance to diabetes. J. Clin. Invest 1980; 65: 896
15 Schleicher E, Scheller L, Wieland O. H. Quantitation of lysine-bound glucose of normal and diabetic erythrocyte membrane proteins by HPLC analysis of furosine. Biochem. Biophys. Res. Commun 1981; 99: 1011
16 Ernst E. Erythrozyten-Abnormalitäten beim Diabetes mellitus. Münchn. med. Wschr 1982; 124: 473
17 Schleicher E, Deufel T, Wieland O. H. Increase in membrane glycosylation and ADP permeability of diabetic erythrocytes. Diabetologia 1981; 21: 324
18 Schuyler M. R, Niewoehner D. E, Inkley S. R, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am. Rev. Respir. Dis 1976; 113: 37
19 Rosenblom A. L, Silverstein J. H, Lezotte D. L, Richardson K, McCallum M. M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. New Engl. J. Med 1981; 305: 191
20 Lawson P. M, Maneschi E, Kohner E. M. The relationship of hand abnormalities to diabetes and diabetic retinopathy. Diabetes Care 1983; 6: 140
21 Cole G. W, Headley J, Skowsky R. Scleredema diabeticorum: A common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 1983; 6: 189
22 Vogt B. W, Schleicher E. D, Wieland O. H. E-Amino lysine bound glucose in human tissues obtained at autopsy: Increase in diabetes mellitus. Diabetes 1982; 31: 1123
23 Schleicher E, Wieland O. H. Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glucosylated proteins: J. Clin. Chem. Clin. Biochem 1981; 19: 81
24 Wieland O. H, Dolhofer R, Schleicher E, Reindl E, Vogt B. Nonenzymatic glucosylation of proteins and possible pathophysiological consequences. In Reutter W. (ed.) Structural Carbohydrates in the Liver MTP Press Ltd. Lancaster in press;
25 Reindl E. Dissertationsarbeit, Universität München. 1983
26 Williams S. K, Howarth N. L, Devenny J. J, Bitensky M. W. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc. Nat. Acad. Sci. USA 1982; 79: 6546
27 Tsai C. S, White J. H. Activation of liver alcohol dehydrogenase by glycosylation. Biochem. J 1983; 209: 309
28 Dolhofer R, Siess E. A, Wieland O. H. Inactivation of bovine kidney B-N-acetyl-D-glucosaminidase by nonenzymatic glucosylation. Hoppe-Seyler’s Z. Physiol. Chem 1982; 363: 1427